Literature DB >> 33881274

Looking back from 2020, how cannabis use and related behaviours changed in Canada.

Michelle Rotermann1.   

Abstract

BACKGROUND: The Canadian government legalized non-medical cannabis use by adults in October 2018 to minimize associated harms and redirect profits from criminals. In October 2019, a wider array of products, including edibles, was legalized, with entry into the legal market beginning in December. DATA AND METHODS: Three quarters (the first quarters of 2018 and 2019 and the fourth quarter of 2020) of the National Cannabis Survey were used to examine changes in cannabis use (overall use and daily or almost daily (DAD) use), consumption methods, products and sources.
RESULTS: Cannabis use in the past three months was higher in late 2020 (20.0%) than in 2019 (17.5%) and 2018 (14.0%), and this was particularly the case among: females (for whom rates rose to equal male rates for the first time), adults aged 25 and older, and some provinces. Similarly, DAD use, at 7.9% also increased. Higher percentages of Canadians reported getting at least some of their cannabis from legal sources or growing it, and fewer were relying on friends and family or illegal sources in 2020. DISCUSSION: This study spans three years-from before legalization to about two years after. It provides a more complete picture of the law's impact on cannabis use and related behaviours, given the more established legal cannabis industry better equipped to compete with the black market on price, convenience and selection. Findings demonstrate that change is continuing, and, as before, some cautions and assurances remain. The impact of the COVID-19 pandemic on cannabis use continues to be difficult to measure. Monitoring remains important, given the ever-changing provincial retail landscapes; the introduction of new products; and the pressure by the industry to remove or adjust potency limits, and allow widespread delivery, farm-gate sales and cannabis lounges.

Entities:  

Keywords:  C-45; Canada; Cannabis Act; controlled and illegal drugs; edibles; legalization; marijuana

Year:  2021        PMID: 33881274     DOI: 10.25318/82-003-x202100400001-eng

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  11 in total

1.  CANreduce-SP-adding psychological support to web-based adherence-focused guided self-help for cannabis users: study protocol for a three-arm randomized control trial.

Authors:  F Fonseca; J I Mestre-Pintó; M P Schaub; C Baumgartner; M Alias-Ferri; M Torrens
Journal:  Trials       Date:  2022-06-22       Impact factor: 2.728

2.  Applying a gendered lens to understanding self-reported changes in alcohol and cannabis consumption during the second wave of the COVID-19 pandemic in Canada, September to December 2020.

Authors:  Kate Hill MacEachern; Jeya Venugopal; Mélanie Varin; Murray Weeks; Nousin Hussain; Melissa M Baker
Journal:  Health Promot Chronic Dis Prev Can       Date:  2021-09-27       Impact factor: 3.240

3.  Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020.

Authors:  Sameer Imtiaz; Samantha Wells; Jürgen Rehm; Christine M Wickens; Hayley Hamilton; Yeshambel T Nigatu; Damian Jankowicz; Tara Elton-Marshall
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-02-21

4.  Online personalized feedback intervention to reduce risky cannabis use. Randomized controlled trial.

Authors:  John A Cunningham; Christina Schell; Nicolas Bertholet; Jeffrey D Wardell; Lena C Quilty; Branka Agic; Alexandra Godinho
Journal:  Internet Interv       Date:  2021-11-14

5.  Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic.

Authors:  Michael J Armstrong; Nathan Cantor; Brendan T Smith; Rebecca Jesseman; Erin Hobin; Daniel T Myran
Journal:  Drug Alcohol Rev       Date:  2022-03-22

6.  Home cultivation across Canadian provinces after cannabis legalization.

Authors:  Elle Wadsworth; Nick Cristiano; Karen Pacheco; Rebecca Jesseman; David Hammond
Journal:  Addict Behav Rep       Date:  2022-03-25

Review 7.  Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.

Authors:  Anaëlle Monfort; Ema Ferreira; Grégoire Leclair; Gregory Anton Lodygensky
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

8.  We need convincing data to support a public health approach to cannabis regulation.

Authors:  Rebecca Jesseman
Journal:  Addiction       Date:  2021-12-10       Impact factor: 7.256

9.  The association between cannabis and codeine use: a nationally representative cross-sectional study in Canada.

Authors:  Ria Garg; Kam Shojania; Mary A De Vera
Journal:  J Cannabis Res       Date:  2022-09-09

10.  Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects.

Authors:  Shankar Tumati; Krista L Lanctôt; RuoDing Wang; Abby Li; Andrew Davis; Nathan Herrmann
Journal:  Drugs Aging       Date:  2021-12-23       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.